Forward Science is a privately held MedTech company based in Houston, TX and founded by two biomedical engineers, Brian Pikkula, PhD and Robert Whitman, MSE. After their cancer research efforts at M.D. Anderson Cancer Center, Forward Science was founded in 2012 with a vision to innovate technologies into simple, efficient, and more affordable options to change lives.
Forward Science’s flagship product is an award-winning oral cancer screening device, OralID. The company also manufactures advanced diagnostic testing products for oral healthcare and treatment options. More recently, they have added a sanitation and PPE line, including their own line of hand sanitizer and surface disinfectant. All products are designed, developed, and manufactured in-house in Stafford, Texas.
“At Forward Science our goal is to provide superior customer service, stable jobs and life-changing technologies. The first few months of 2020 challenged Forward Science, and every business, to focus even more heavily on taking care of our community. We are proud to continue creating innovative products and providing solutions during this unprecedented time,” said Forward Science CEO, Robert Whitman.
BoyarMiller has helped Forward Science with a variety of different contracts along with capital formation and employment matters, much of our work centered around advancing the successful growth of the company. “It has been so engaging to represent Forward Science as their company grows, especially to see them take the challenges of COVID-19 and find ways to increase their business,” said BoyarMiller Shareholder Gary Miller. “I am impressed by their ability to pivot and add new product lines such as PPE that are in high demand at this time.”
Learn more about Forward Science here: www.forwardscience.com.